H I J Roest

Summary

Affiliation: Wageningen University
Country: The Netherlands

Publications

  1. pmc Q fever in pregnant goats: humoral and cellular immune responses
    Hendrik I J Roest
    Department of Bacteriology and TSEs, Central Veterinary Institute, part of Wageningen University and Research Centre, Edelhertweg 15, Lelystad, PH, 8219, The Netherlands
    Vet Res 44:67. 2013
  2. pmc Q fever in pregnant goats: pathogenesis and excretion of Coxiella burnetii
    Hendrik Jan Roest
    Department of Bacteriology and TSEs, Central Veterinary Institute, Wageningen University and Research Centre, Lelystad, The Netherlands
    PLoS ONE 7:e48949. 2012
  3. ncbi request reprint [Two horses with neurological symptoms: could this be equine botulism?]
    H I J Roest
    Divisie Bacteriologie en TSE s, Centraal Veterinair Instituut van Wageningen UR, Lelystad, Nederland
    Tijdschr Diergeneeskd 134:790-5. 2009
  4. doi request reprint The Q fever epidemic in The Netherlands: history, onset, response and reflection
    H I J Roest
    Department of Bacteriology and TSEs, Central Veterinary Institute of Wageningen UR, Lelystad, The Netherlands
    Epidemiol Infect 139:1-12. 2011
  5. pmc Molecular epidemiology of Coxiella burnetii from ruminants in Q fever outbreak, the Netherlands
    Hendrik I J Roest
    Central Veterinary Institute, part of Wageningen UR, Lelystad, The Netherlands
    Emerg Infect Dis 17:668-75. 2011
  6. doi request reprint Q fever diagnosis and control in domestic ruminants
    H I J Roest
    Department of Bacteriology and TSEs, Central Veterinary Institute, part of Wageningen UR, Lelystad, The Netherlands
    Dev Biol (Basel) 135:183-9. 2013

Detail Information

Publications6

  1. pmc Q fever in pregnant goats: humoral and cellular immune responses
    Hendrik I J Roest
    Department of Bacteriology and TSEs, Central Veterinary Institute, part of Wageningen University and Research Centre, Edelhertweg 15, Lelystad, PH, 8219, The Netherlands
    Vet Res 44:67. 2013
    ..This humoral immune response may be useful in the early detection of C. burnetii-infected pregnant goats. ..
  2. pmc Q fever in pregnant goats: pathogenesis and excretion of Coxiella burnetii
    Hendrik Jan Roest
    Department of Bacteriology and TSEs, Central Veterinary Institute, Wageningen University and Research Centre, Lelystad, The Netherlands
    PLoS ONE 7:e48949. 2012
    ..Besides abortions, normal deliveries in C. burnetii-infected goats should be considered as a major zoonotic risk for Q fever in humans...
  3. ncbi request reprint [Two horses with neurological symptoms: could this be equine botulism?]
    H I J Roest
    Divisie Bacteriologie en TSE s, Centraal Veterinair Instituut van Wageningen UR, Lelystad, Nederland
    Tijdschr Diergeneeskd 134:790-5. 2009
    ..As long as no vaccine is available in the Netherlands quality control of silage and haylage is strictly recommended in order to reduce the risk of botulism in horses...
  4. doi request reprint The Q fever epidemic in The Netherlands: history, onset, response and reflection
    H I J Roest
    Department of Bacteriology and TSEs, Central Veterinary Institute of Wageningen UR, Lelystad, The Netherlands
    Epidemiol Infect 139:1-12. 2011
    ..In general good monitoring and surveillance systems are necessary to assess the real magnitude of Q fever...
  5. pmc Molecular epidemiology of Coxiella burnetii from ruminants in Q fever outbreak, the Netherlands
    Hendrik I J Roest
    Central Veterinary Institute, part of Wageningen UR, Lelystad, The Netherlands
    Emerg Infect Dis 17:668-75. 2011
    ..On the basis of 4 loci, this genotype is similar to a human genotype from the Netherlands. This finding strengthens the probability that this genotype of C. burnetii is responsible for the human Q fever epidemic in the Netherlands...
  6. doi request reprint Q fever diagnosis and control in domestic ruminants
    H I J Roest
    Department of Bacteriology and TSEs, Central Veterinary Institute, part of Wageningen UR, Lelystad, The Netherlands
    Dev Biol (Basel) 135:183-9. 2013
    ..Furthermore, the complicated vaccine production process, requiring biosafety level 3 facilities, could hamper vaccine availability. Future challenges include the development of improved, easier to produce Q fever vaccines...